Food grade Lactococcus lactis has been widely used as an antigen and DNA delivery vehicle. We have previously reported the use of non-invasive L. lactis to deliver the newly constructed immunostimulatory DNA vaccine reporter plasmid, pPERDBY. In the present report, construction of dual recombinant L. lactis expressing internalin A of Listeria monocytogenes and harboring pPERDBY (LL InlA þ pPERDBY) to enhance the efficiency of delivery of DNA by L. lactis is outlined. After confirmation and validation of LL InlA þ pPERDBY, its DNA delivery potential was compared with previously developed non-invasive r-L. lactis::pPERDBY. The use of invasive L. lactis resulted in around threefold increases in the number of enhanced green fluorescent protein-expressing Caco-2 cells. These findings reinforce the prospective application of invasive strain of L. lactis for delivery of DNA/RNA and antigens.
In the present era there have been tremendous advances in development of prophylactic vaccines against prevailing infectious diseases. The success of several of these vaccines relies on efficient elicitation of both mucosal and systemic immunity (1) . Mucosal immunity plays a key role in inhibition and clearance of pathogen in the initial stage of infection. Various bacterial carriers have successfully been exploited to deliver protein antigens and plasmid DNA to different mucosal sites with the aim of generating mucosal immunity (2) . The invasion potential of numerous attenuated pathogens such as Salmonella, Shigella, Yersinia and Listeria has been utilized to attain enhanced antigen/DNA delivery. However, reversion to their native virulent form and associated safety concerns have precluded their use as delivery vehicles (3) .
In a search for better alternatives, Lactococcus lactis has emerged as an attractive delivery vehicle with an extremely safe profile. L. lactis, which has Generally Regarded as Safe status, is widely used in the food industry and its use to deliver therapeutic proteins is well-established (4) . The ability of L. lactis to pass through the intestinal tract without colonizing it has increased the avenues for its deployment as an efficient delivery vehicle for antigens and DNA to various mucosal sites, such as oral, nasal and vaginal mucosa (5) .
We have expressed outer membrane protein A of Shigella dysenteriae type-1 in L. lactis (6) and evaluated its immunogenic potential at two established conventional mucosal sites, that is, oral and intranasal (7) . Moreover, using our newly developed active shigellosis murine model (8) , we have assessed the protective efficacy of r-L. lactis vaccine candidate (unpublished data). Recently, we have also reported the potential of non-invasive L. lactis harboring newly constructed immunodominant pPERDBY to serve as a DNA delivery vehicle (9) . However, non-invasive L. lactis is relatively inefficient at such delivery compared with the attenuated pathogens that are used for DNA delivery (10) .
The ability of non-invasive L. lactis to deliver DNA reportedly requires efficient cell attachment in successful internalization and subsequent DNA delivery inside Caco-2 cells (9) . Some proteins of invasive pathogens, namely InlA of Listeria monocytogenes and fibronectin binding protein A of Staphylococcus aureus, have been expressed in L. lactis to augment its efficiency in delivering DNA (11) . InlA is an invasion protein that binds to E-cadherin expressed on human epithelial cells. The receptor-ligand interaction allows bacterial entry to the cell, leading to enhanced DNA delivery to the nucleus (12) .
The immunostimulatory properties and small size ($4.8 kb) of the previously constructed DNA vaccine reporter plasmid pPERDBY indicate its potential in DNA vaccination. Enhanced delivery of this developed DNA vaccine plasmid boosts the desired immune response against the selected antigen. With this aim, the present study describes the construction and validation of dual recombinant L. lactis expressing InlA of Listeria monocytogenes and pPERDBY. We also compared the efficiency with which invasive and noninvasive L. lactis deliver DNA in this study.
MATERIALS AND METHODS

Bacterial strains, plasmids and growth conditions
Details of bacterial strains and plasmids used in this study are described in Table 1 and Supplementary Figure S1 .
Escherichia coli DH5a was grown at 37°C and 180 rpm in LB medium, whereas L. lactis was grown statically at 30°C in M17 medium (Difco Laboratories, Franklin Lakes, NJ, USA) supplemented with 0.5% (w/v) sterile glucose (GM17). Antibiotics were added at the indicated concentrations as follows; chloramphenicol (10 mg/mL for L. lactis and E. coli) and erythromycin (150 mg/mL for E. coli and 5 mg/ml for L. lactis).
DNA manipulation
Plasmid DNA was extracted from E. coli as described previously (13) . For isolation of plasmid DNA from L. lactis, TES (50 mM Tris-HCl, 1 mM EDTA, 25% sucrose, pH 8) containing lysozyme (10 mg/mL) was added to the overnight grown culture for 10 min at 37°C to prepare protoplasts. Competent cell preparation and electroporation of L. lactis were performed as described previously (6) . Enzymes for restriction enzyme digestion, PCR and RT-PCR were used as recommended by manufacturer.
Construction of dual recombinant L. lactis strain
For construction of the dual recombinant LL InlA þ pPERDBY, L. lactis NZ9000 was transformed simultaneously with two plasmids, pPERDBY and pGM10 by electroporation ( Supplementary Fig. S1 ). Transformants were selected on GM17 agar plates containing appropriate concentrations of chloramphenicol and erythromycin. Dual recombinant L. lactis clones were screened by colony PCR using InlA and EGFP specific primers (Table 2 ; data not shown). Functional evaluation of dual recombinant strain was carried out by determining expression of InlA, followed by ascertaining the presence and functional integrity of DNA vaccine reporter plasmid, pPERDBY. Dual recombinant L. lactis strain (LL InlA þ pPERDBY) was preserved as a glycerol stock at À80°C till further use. (9) Chloramphenicol (Cm) was used at 10 mg/mL for E. coli and L. lactis and erythromycin at 150 mg/mL for E. coli and 5 mg/mL for L. lactis. CM, chloramphenicol; Ery, erythromycin. 
Stability of LL InlA þ pPERDBY
The stability of pGM10 and pPERDBY in dual recombinant L. lactis was evaluated as described previously (14) with minor modifications. Briefly, a frozen glycerol stock of LL InlA þ pPERDBY was diluted (1:25) in GM17 broth and grown to OD 600 of 0.9. The preliminary culture was further sub-cultured at least 25 times in GM17 broth and grown at 30°C statically. Both cultures were plated on GM17 agar with or without chloramphenicol (10 mg/mL) and erythromycin (5 mg/mL) and incubated at 30°C for 16 hr. The numbers of CFU recovered on GM17 agar plates containing both antibiotics and GM17 agar plates devoid of any antibiotic were compared to evaluate the stability of both plasmids (pPERDBY and pGM10) in LL InlA þ pPERDBY.
RNA isolation and detection of InlA and EGFP specific transcripts by RT-PCR
RNA was isolated from bacterial and mammalian cells using a GeneJet RNA Purification kit (Thermo Fischer Scientific, Pittsburgh, PA, USA). For L. lactis, freshly grown cells were harvested by centrifugation and re-suspended in Tris-EDTA buffer containing 10 mg/mL of lysozyme for 30 minutes. The resulting protoplasts of L. lactis cells were then subjected to a treatment with a GeneJet RNA purification kit. Similarly, RNA was also isolated from transfected Caco-2 and co-cultured Caco-2 cells. RT-PCR was performed from 1 mg of total RNA using a Maxima cDNA synthesis kit (Thermo Fischer Scientific). InlA and EGFP transcripts were detected using the primers listed in Table 2 .
Transfection of Caco-2 cells
Caco-2 cells were transfected with plasmids isolated from dual recombinant LL InlA þ pPERDBY for assessment of EGFP expression. Caco-2 cells were maintained in Dulbecco's modified eagle medium supplemented with 10% FBS, 100 U penicillin and 100 g streptomycin. Around 70% confluent Caco-2 cells were transfected with plasmids isolated from LL InlA þ pPERDBY using Lipofectamine LTX Plus transfection reagent (Invitrogen, Carlsbad, CA, USA) as recommended by the manufacturer. Plasmids; pPERDBY and pGM10 were used as positive and negative controls, respectively. EGFP expression was assessed at 72 hr post transfection with an epifluorescent microscope (Olympus Model IX51; Olympus, Tokyo, Japan).
Delivery of pPERDBY to Caco-2 cells using invasive and non-invasive L. lactis
The human intestinal epithelial cell line Caco-2 was used to compare the delivery potentials of invasive and noninvasive strains. Bacterial strains were grown to an OD 600 of 0.9-1.0, pelleted and washed in PBS (10 mM Na 2 HPO 4 ; 137 mM NaCl; 2.7 mM KCl and 1.8 mM K 2 HPO 4 ), then added to the Caco-2 cells at an MOI of approximately 10 3 bacteria per eukaryotic cell. A gentamicin survival assay was used to evaluate internalization of bacteria into the Caco-2 cells (9). Briefly, recombinant, dual recombinant or wild type L. lactis strain was applied on the apical side of eukaryotic cells and co-incubated for an hour at 37°C in 5% CO 2 . After incubation, cells were washed to remove noninternalized bacteria and 200 mg/mL of gentamicin added for an incubation period of 2 hr to kill the 
Quantification of internalized bacteria
Caco-2 cells co-cultured with different L. lactis strains were lysed with 0.2% Triton X-100 diluted in water after gentamicin treatment. Serial dilutions of the cell lysates were plated on GM17 agar and incubated at 30°C for 16 hr. CFUs of intracellular bacteria were expressed as the average of three independent gentamicin assays performed in triplicate. The invasion rate was calculated as the ratio of CFU counts.
Statistical analyses
The results are expressed as mean AE standard error. Statistical significance was calculated using Student's t-test and one way anova followed by the Bonferroni post-test. Values of P < 0.05 were considered to denote significance.
RESULTS
Construction of dual recombinant LL InlA þ pPERDBY
Construction of dual recombinant L. lactis strain harboring pPERDBY and pGM10 was confirmed by evaluating expression of InlA, followed by assessing the presence and functional integrity of the DNA vaccine reporter, pPERDBY.
Confirmation of InlA expression in L. lactis
Total RNA isolated LL InlA þ pPERDBY, was subjected to RT-PCR using InlA specific primers. Presence of a $750 bp fragment (Fig. 1a, Lane 4) indicated successful expression of InlA in LL InlA þ pPERDBY. L. lactis transformed with pPERDBY served as a negative control and r-L. lactis harboring pGM10 as a positive control.
Confirmation of presence of pPERDBY
The presence of pPERDBY plasmid in LL InlA þ pPERDBY strain was confirmed by amplification of the egfp gene. Plasmid DNA isolated from strain LL InlA þ pPERDBY was subjected to PCR using egfp specific primers. Purified pPERDBY and pGM10 plasmids were used as positive and negative controls, respectively. As shown in Figure 1b , the presence of a $1800 bp fragment in LL InlA þ pPERDBY strain confirmed the presence of pPERDBY in the dual recombinant L. lactis strain. However, amplification was not observed with purified pGM10 plasmid (negative control).
Confirmation of functional integrity of pPERDBY in LL InlA þ pPERDBY
To evaluate the functional integrity of pPERDBY in LL InlA þ pPERDBY strain, plasmids isolated from dual recombinant strain were used to transfect Caco-2 cells. Purified pPERDBY (positive control), pGM10 (negative control) and a mixture of pGM10þpPERDBY plasmids (internal positive control) were also used to transfect Caco-2 cells. After 72 hr of transfection, the cells were examined for EGFP expression. Caco-2 cell transfected with plasmids isolated from LL InlA þ pPERDBY strain exhibited EGFP expression, confirming the functional integrity of pPERDBY in dual recombinant LL InlA þ pPERDBY (Fig. 1c) .
Stability of pGM10 and pPERDBY in dual recombinant L. lactis
The stability of pPERDBY and pGM10 in LL InlA þ pPERDBY was evaluated after repeated sub-culturing. It was found that around 90% of cells revived and formed colonies on GM17 agar in the absence of both the antibiotics; whereas around 94% of cells revived and formed colonies in the presence of chloramphenicol and erythromycin (data not shown); suggesting both plasmids in dual recombinant L. lactis are stable.
Comparison of efficiency with which invasive and non-invasive L. lactis strains deliver DNA
EGFP expression at the RNA level
To compare the efficiency with which invasive and non-invasive L. lactis deliver pPERDBY, total RNA was isolated from Caco-2 cells, which were co-cultured with r-L. lactis::pPERDBY and LL InlA þ pPERDBY. Caco-2 cells transfected with pPERDBY were used as a positive control. The egfp transcripts were then detected by RT-PCR. As shown in Figure 2a , a 350 bp amplicon supported expression of egfp transcripts in both the co-cultured Caco-2 cells. However, the relative expression of egfp transcripts appeared to differ between Caco-2 cells cultured with invasive L. lactis (LL InlA þ pPERDBY) and those cultured with non-invasive L. lactis (r-L. lactis::pPERDBY). Relative quantification of egfp transcripts revealed significantly greater (P < 0.0001) egfp expression in Caco-2 cells cocultured with dual recombinant LL InlA þ pPERDBY (Fig. 2b) . This result suggests the invasive strain of L. lactis has better delivery potential than the noninvasive strain.
EGFP expression at protein level
As shown in Figure 2c , EGFP expression was detected in both Caco-2 cells co-cultured with r-L. lactis::pPERDBY and Caco-2 cells co-cultured with LL InlA þ pPERDBY; whereas, fluorescence was not observed in Caco-2 cells co-cultured with wild type L. lactis NZ9000 (negative control). These results indicate that both invasive and non-invasive L. lactis successful delivered pPERDBY.
Quantification of internalized bacteria
The efficiency of DNA delivery is influenced by the number of bacteria internalized in eukaryotic cells (5) . To ascertain differences in the number of internalized bacteria, CFU studies were performed. Significantly more (P < 0.048) bacteria were found to be internalized in Caco-2 cells that were co-cultured with the invasive dual recombinant strain (LL InlA þ pPERDBY) than in Caco-2 cells co-cultured with the non-invasive strain (r-L. lactis:pPERDBY). This observation clearly suggests that invasive L. lactis has greater potential to deliver the plasmid DNA (Fig. 3a) .
FACS analysis
Co-cultured Caco-2 cells expressing EGFP were quantified by FACS analysis. Around 1.4% of Caco-2 cells co-cultured with LL InlA þ pPERDBY expressed EGFP (Fig. 3b) , whereas our previous study using non-invasive r-L. lactis:pPERDBY reported only 0.53% of EGFP positive Caco-2 cells (9).
DISCUSSION
Over the last two decades, L. lactis has emerged as an attractive alternative to numerous invasive pathogens for the delivery of a wide range of molecules to host immune systems (4). In our previous study, we found that non-invasive L. lactis successfully delivered newly constructed DNA vaccine reporter plasmid pPERDBY to Caco-2 (9) . To improve the delivery of pPERDBY to Caco-2 cells, we here employed expression of InlA protein of Listeria monocytogenes on L. lactis. The ability of other invasion molecules such as fibronectin binding protein A and mutant InlA to enhance the efficiency with which L. lactis delivers DNA have also been explored (5, 11) . Further, the efficiency with which invasive and non-invasive L. lactis deliver DNA was compared at RNA and protein levels after co-culture with Caco-2 cells.
More EGFP specific transcripts were obtained from the Caco-2 cells co-incubated with invasive strains than from those cultured with the non-invasive strain, indicating InlA expressing L. lactis have greater DNA delivery potential. Similarly, co-incubation of Caco-2 cells with the invasive strain resulted in 1.4% of EGFP positive cells, whereas we obtained only 0.53% of EGFP positive cells using the non-invasive strain (9) . The observed threefold increase in percentage of EGFP expressing Caco-2 cells reinforces the rationale of employing InlA to enhance DNA delivery by L. lactis.
DNA delivery to epithelial cells by L. lactis largely depends on bacterial adhesion and invasion (5, 9, 11, 15, 16) . We found significantly higher bacterial counts in Caco-2 cells co-cultured with the invasive strain than with the noninvasive strain. The greater internalized bacterial count and subsequent enhanced DNA delivery may be attributable to increased adhesion potential and E-cadherin receptor-mediated endocytosis inside the epithelial cells of invasive L. lactis (LL InlA þ pPERDBY). These findings strengthen our previously postulate concerning DNA delivery to epithelial cells by L. lactis (9) . The findings of the present study support the conclusion that live invasive L. lactis successfully internalized and delivered pPERDBY to the nucleus, resulting in EGFP expression. The exact mechanism of delivery of pPERDBY to the nucleus is not clear. However, a number of reports have proposed that plasmid DNA is delivered following the death of internalized bacteria (including L. lactis) by phagolysosome action (5, 12, (17) (18) (19) .
In conclusion (Fig. 4) , pPERDBY is efficiently delivered in vitro by recombinant L. lactis expressing InlA. We found by RT-PCR and FACS analysis that the invasive strain of L. lactis is superior to its non-invasive counterpart at delivering DNA. Moreover, the stability of both plasmids in preserved glycerol stock of LL InlA þ pPERDBY strengthens its potential as a prospective vaccine candidate. Because murine E-cadherin cannot bind with InlA, the developed invasive L. lactis strain cannot be studied in mice. However, guinea pig and human homologs of E-cadherin are known to bind efficiently to InlA of L. monocytogenes, raising the possibility of evaluating the efficiency with which invasive L. lactis delivers DNA in vivo (12) . Successful in vivo DNA delivery by invasive L. lactis would encourage us to deliver antigens of enteric pathogens such as Shigella and Salmonella at mucosal sites. Prospective applications of developed invasive L. lactis harboring immunostimulatory DNA vaccine plasmid include delivery of DNA vaccines, RNA and/or therapeutic bioactive peptides. The safety assessment of such developed vaccine candidates is yet to be evaluated and would encourage its clinical use in humans. Accordingly, toxicity and other safety parameters of LL InlA þ pPERDBY are currently being studied in our lab.
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